Mutual Inhibition of Antithrombin III and SARS-CoV-2 Cellular Attachment to Syndecans: Implications for COVID-19 Treatment and VaccinationArticle Published on 2024-07-092024-09-05 Journal: International Journal of Molecular Sciences [Category] update2024, [키워드] antithrombin III heparan sulfate proteoglycans SARS-CoV-2 spike protein cellular entry syndecans [DOI] 10.3390/ijms25147534 PMC 바로가기 [Article Type] Article
Coagulation Parameters in Post-Covid-19 Condition in Relation to Various Titers of Anti-SARS-CoV-2 IgG in Blood PlasmaOriginal Research Published on 2023-12-272024-09-05 Journal: International Journal of General Medicine [Category] update2024, [키워드] antithrombin III long-COVID protein C thrombomodulin [DOI] 10.2147/IJGM.S425496 PMC 바로가기 [Article Type] Original Research
Antithrombin III activity is associated with prognosis, infection, and inflammation in patients with hepatitis B virus-related acute-on-chronic liver failureOriginal Articles: Hepatology Published on 2023-08-282024-09-05 Journal: European Journal of Gastroenterology & Hepatology [Category] update2024, [키워드] antithrombin III Infection Inflammation liver failure Prognosis [DOI] 10.1097/MEG.0000000000002571 PMC 바로가기 [Article Type] Original Articles: Hepatology
Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections세린 프로테아제 억제제는 SARS-CoV-2 감염에 대한 숙주 감수성을 제한합니다Article Published on 2022-06-282022-09-11 Journal: mBio [Category] COVID19(2023년), SARS, 유전자 메커니즘, 치료제, [키워드] A1AT acute respiratory syndrome Administered Affect affecting age Alpha alpha-1-antitrypsin antithrombin III antitrypsin Antiviral antiviral drug antiviral intervention approach asymptomatic infection asymptomatic infections ATIII can be used cellular cellular protease ciliated cleavage club Comorbidities Comorbidity complex coronavirus disease Coronavirus disease 2019 COVID-19 deficiency determinant determinants disease disease severity Donor door expression expression level Factor Genetic Genetic variation Genetic variations goblet cells highlight Host human donors identification identify identity immune response individual Infection inhibitor inhibitors less lung cell mechanism mechanism of action outcome PAI1 Patient patients plasminogen activator inhibitor 1 Potential potential treatments primary cell primary cells reduce reducing regulate restrict risk risk factor Risk factors SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 susceptibility Serine serine protease serine protease inhibitor serine protease inhibitors serpin serpin. SERPINA1 SERPINE1 SERPINE2 serpins Severe acute respiratory syndrome severe COVID-19 severe infections Sex Single-cell RNA sequencing Spike protein susceptibility susceptible Symptom target cells TMPRSS2 Treatment Usage Variation viral burden viral entry viral spike protein [DOI] 10.1128/mbio.00892-22 PMC 바로가기 [Article Type] Article
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-FactorsCOVID-19 회복기 혈장은 중화 항체 이상입니다 : 잠재적 인 유익하고 유해한 공동 요인에 대한 이야기 검토Review Published on 2021-08-112022-09-01 Journal: Viruses [Category] MERS, SARS, 진단, [키워드] ADAMTS13 Alpha antibody affinity antithrombin III ARMS autoantibodies causal link CCP CCP therapy characterized Clinical efficacy component contribute controlled trials convalescent plasma COVID-19 COVID-19 convalescent plasma decoy receptors detrimental Effect Extracellular vesicles Factor fresh frozen plasma frozen plasma heterologous immunity highlight interferons MDA5 narrative Neutralizing antibodies neutralizing antibody outcome patients with COVID-19 plasma Potential Prophylaxis randomized clinical trial randomized clinical trials reported retrospective review Safe specific antibodies thrombosis Treatment variations [DOI] 10.3390/v13081594 PMC 바로가기 [Article Type] Review
Understanding the andromeda strain – The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness안드로메다 균주 이해 - SARS-CoV2 중병에서 사이토카인 방출, 응고병증 및 안티트롬빈 III의 역할Review Published on 2021-01-012022-09-11 Journal: Blood reviews [Category] SARS, 바이오마커, [키워드] Antithrombin antithrombin III autopsy analysis benefit China circulating Coagulation Coagulopathy coronavirus COVID-19 COVID-19 infections Critical Critical illness cytokine release Europe globe hematology heparin Heparin resistance mediator Microthrombosis Mortality Multiple observational studies observational study organizations pandemic Part pathology pathophysiology Patient performed physician potential therapeutic target Prognostic marker Prophylactic prothrombotic reduction reductions reported SARS-CoV SARS-CoV critical illness SARS-CoV2 severe COVID-19 infections Society temper thrombosis thrombotic thrombotic complication Thrombotic complications understanding [DOI] 10.1016/j.blre.2020.100731 PMC 바로가기 [Article Type] Review
COVID-19-Associated Acute Limb Ischemia in a Patient on Therapeutic AnticoagulationInternal Medicine Published on 2020-09-252022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute arterial thrombosis acute respiratory syndrome Anticoagulant antithrombin III caused Chronic kidney disease Coagulopathy Complication coronavirus Coronavirus disease 2019 COVID 19 covid coagulopathy COVID-19 COVID-19 infection D-dimer deficiency diabete diagnosis of COVID-19 died Disseminated intravascular coagulation Disseminated intravascular coagulation (DIC) element elevated favor fondaparinux Hemostatic heparin heparin-induced thrombocytopenia heparin-induced thrombocytopenia (hit) highlight hypercoagulability Hypercoagulable state hyperlipidemia hypertension hypoxia hypoxic respiratory failure Ischemia iteration limb mechanism Mental oral medications organ system Oxygen requirement Patient patients with COVID-19 performed physical exam Platelet Prevent question raise raising required resulting SARS-CoV-2 significantly surgical therapeutic anticoagulation thrombosis virus [DOI] 10.7759/cureus.10655 PMC 바로가기 [Article Type] Internal Medicine
Role of Both Protein C and Antithrombin III as Predictors of Stage of Liver Disease in Chronic Viral Hepatitis B or C Infected PatientsArticle Published on 2020-01-012023-06-13 Journal: Endocrine, metabolic & immune disorders drug targets [Category] B형 간염, [키워드] Anticoagulants antithrombin III chronic liver disease hepatitis B hepatitis C protein C [DOI] 10.2174/1871530319666190529092555